ID MOGS_MOUSE Reviewed; 834 AA. AC Q80UM7; Q9Z2W5; DT 07-JUN-2004, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2003, sequence version 1. DT 24-JAN-2024, entry version 150. DE RecName: Full=Mannosyl-oligosaccharide glucosidase {ECO:0000305}; DE EC=3.2.1.106 {ECO:0000250|UniProtKB:Q13724}; DE AltName: Full=Endoplasmic reticulum alpha-glucosidase I {ECO:0000303|PubMed:21183079}; DE Short=ER glu I {ECO:0000303|PubMed:21183079}; DE AltName: Full=Glucosidase 1; DE AltName: Full=Glycoprotein-processing glucosidase I {ECO:0000305|PubMed:10406845}; GN Name=Mogs {ECO:0000312|MGI:MGI:1929872}; GN Synonyms=Gcs1 {ECO:0000312|MGI:MGI:1929872}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] {ECO:0000312|EMBL:AAD00906.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=10406845; DOI=10.1093/glycob/9.8.797; RA Khan F.A., Varma G.M., Vijay I.K.; RT "Genomic organization and promoter activity of glucosidase I gene."; RL Glycobiology 9:797-806(1999). RN [2] {ECO:0000312|EMBL:AAH51949.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Fetal brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [4] {ECO:0007744|PDB:5MHF} RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 59-834 IN COMPLEX WITH A RP DEOXYNOJIRIMYCIN DERIVATIVE INHIBITOR, FUNCTION (MICROBIAL INFECTION), AND RP ACTIVITY REGULATION. RX PubMed=32227946; DOI=10.1021/acs.jmedchem.0c00067; RA Warfield K.L., Alonzi D.S., Hill J.C., Caputo A.T., Roversi P., RA Kiappes J.L., Sheets N., Duchars M., Dwek R.A., Biggins J., Barnard D., RA Shresta S., Treston A.M., Zitzmann N.; RT "Targeting endoplasmic reticulum alpha-glucosidase I with a single-dose RT iminosugar treatment protects against lethal Influenza and Dengue virus RT infections."; RL J. Med. Chem. 63:4205-4214(2020). CC -!- FUNCTION: In the context of N-glycan degradation, cleaves the distal CC alpha 1,2-linked glucose residue from the Glc(3)Man(9)GlcNAc(2) CC oligosaccharide precursor in a highly specific manner. CC {ECO:0000250|UniProtKB:Q13724}. CC -!- FUNCTION: (Microbial infection) Required for successful influenza or CC dengue virus infection; inhibition of its activity by a CC deoxynojirimycin derivative prevents death in mice infected with lethal CC doses of influenza or dengue viruses, even when administrated after CC infection. {ECO:0000269|PubMed:32227946}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N(4)-(alpha-D-Glc-(1->2)-alpha-D-Glc-(1->3)-alpha-D-Glc- CC (1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)- CC [alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D- CC Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc- CC (1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] = beta-D-glucose + CC N(4)-(alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha- CC D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man- CC (1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]- CC beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl- CC [protein]; Xref=Rhea:RHEA:55988, Rhea:RHEA-COMP:12806, Rhea:RHEA- CC COMP:14355, ChEBI:CHEBI:15377, ChEBI:CHEBI:15903, ChEBI:CHEBI:59082, CC ChEBI:CHEBI:132537; EC=3.2.1.106; CC Evidence={ECO:0000250|UniProtKB:Q13724}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55989; CC Evidence={ECO:0000250|UniProtKB:Q13724}; CC -!- ACTIVITY REGULATION: Inhibited by the deoxynojirimycin derivative N-9'- CC Methoxynonyl-1-Deoxynojirimycin. {ECO:0000269|PubMed:32227946}. CC -!- PATHWAY: Glycan metabolism; N-glycan degradation. CC {ECO:0000250|UniProtKB:Q13724}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:Q13724}; Single-pass type II membrane protein CC {ECO:0000250|UniProtKB:O88941}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 63 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF001797; AAD00906.1; -; Genomic_DNA. DR EMBL; BC051949; AAH51949.1; -; mRNA. DR CCDS; CCDS20273.1; -. DR RefSeq; NP_065644.2; NM_020619.2. DR PDB; 5MHF; X-ray; 2.10 A; A/B/C/D=59-834. DR PDBsum; 5MHF; -. DR AlphaFoldDB; Q80UM7; -. DR SMR; Q80UM7; -. DR BioGRID; 208276; 8. DR IntAct; Q80UM7; 3. DR STRING; 10090.ENSMUSP00000032114; -. DR ChEMBL; CHEMBL4523366; -. DR CAZy; GH63; Glycoside Hydrolase Family 63. DR GlyCosmos; Q80UM7; 1 site, No reported glycans. DR GlyGen; Q80UM7; 2 sites, 1 O-linked glycan (1 site). DR iPTMnet; Q80UM7; -. DR PhosphoSitePlus; Q80UM7; -. DR SwissPalm; Q80UM7; -. DR EPD; Q80UM7; -. DR jPOST; Q80UM7; -. DR MaxQB; Q80UM7; -. DR PaxDb; 10090-ENSMUSP00000032114; -. DR ProteomicsDB; 295578; -. DR Pumba; Q80UM7; -. DR Antibodypedia; 2372; 198 antibodies from 25 providers. DR DNASU; 57377; -. DR Ensembl; ENSMUST00000032114.8; ENSMUSP00000032114.8; ENSMUSG00000030036.9. DR GeneID; 57377; -. DR KEGG; mmu:57377; -. DR UCSC; uc009cmn.1; mouse. DR AGR; MGI:1929872; -. DR CTD; 7841; -. DR MGI; MGI:1929872; Mogs. DR VEuPathDB; HostDB:ENSMUSG00000030036; -. DR eggNOG; KOG2161; Eukaryota. DR GeneTree; ENSGT00390000017452; -. DR HOGENOM; CLU_007380_1_0_1; -. DR InParanoid; Q80UM7; -. DR OMA; FNWYNTT; -. DR OrthoDB; 1571at2759; -. DR PhylomeDB; Q80UM7; -. DR TreeFam; TF300749; -. DR UniPathway; UPA00280; -. DR BioGRID-ORCS; 57377; 28 hits in 83 CRISPR screens. DR ChiTaRS; Mogs; mouse. DR PRO; PR:Q80UM7; -. DR Proteomes; UP000000589; Chromosome 6. DR RNAct; Q80UM7; Protein. DR Bgee; ENSMUSG00000030036; Expressed in primitive streak and 266 other cell types or tissues. DR GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central. DR GO; GO:0004573; F:Glc3Man9GlcNAc2 oligosaccharide glucosidase activity; IBA:GO_Central. DR GO; GO:0009311; P:oligosaccharide metabolic process; IEA:InterPro. DR GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central. DR Gene3D; 1.50.10.10; -; 1. DR Gene3D; 2.70.98.110; Glycosyl hydrolase family 63, N-terminal domain; 1. DR InterPro; IPR008928; 6-hairpin_glycosidase_sf. DR InterPro; IPR012341; 6hp_glycosidase-like_sf. DR InterPro; IPR031335; Glyco_hydro_63_C. DR InterPro; IPR031631; Glyco_hydro_63N. DR InterPro; IPR038518; Glyco_hydro_63N_sf. DR InterPro; IPR004888; Glycoside_hydrolase_63. DR PANTHER; PTHR10412; MANNOSYL-OLIGOSACCHARIDE GLUCOSIDASE; 1. DR PANTHER; PTHR10412:SF11; MANNOSYL-OLIGOSACCHARIDE GLUCOSIDASE; 1. DR Pfam; PF03200; Glyco_hydro_63; 1. DR Pfam; PF16923; Glyco_hydro_63N; 1. DR SUPFAM; SSF48208; Six-hairpin glycosidases; 1. DR Genevisible; Q80UM7; MM. PE 1: Evidence at protein level; KW 3D-structure; Endoplasmic reticulum; Glycoprotein; Glycosidase; Hydrolase; KW Membrane; Reference proteome; Signal-anchor; Transmembrane; KW Transmembrane helix. FT CHAIN 1..834 FT /note="Mannosyl-oligosaccharide glucosidase" FT /id="PRO_0000057711" FT TOPO_DOM 1..43 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 44..64 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 65..834 FT /note="Lumenal" FT /evidence="ECO:0000255" FT REGION 1..37 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 74..136 FT /note="Required for endoplasmic reticulum targeting" FT /evidence="ECO:0000250" FT MOTIF 3..9 FT /note="Endoplasmic reticulum targeting" FT COMPBIAS 1..30 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 580 FT /note="Proton donor" FT /evidence="ECO:0000305|PubMed:32227946" FT ACT_SITE 804 FT /note="Proton acceptor" FT /evidence="ECO:0000305|PubMed:32227946" FT CARBOHYD 654 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000250|UniProtKB:Q13724" FT CONFLICT 749 FT /note="G -> S (in Ref. 1; AAD00906)" FT /evidence="ECO:0000305" FT HELIX 63..69 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 81..84 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 86..88 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 90..92 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 93..95 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 101..109 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 114..123 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 144..150 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 152..162 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 165..174 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 177..180 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 182..191 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 201..209 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 228..233 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 234..236 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 237..243 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 258..265 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 269..271 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 272..279 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 282..286 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 294..299 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 315..335 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 336..338 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 342..345 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 351..365 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 368..370 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 382..397 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 400..404 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 407..409 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 429..433 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 446..459 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 461..472 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 483..485 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 489..492 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 497..499 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 513..522 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 525..532 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 535..548 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 575..577 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 595..615 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 618..632 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 634..641 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 644..647 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 652..655 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 659..664 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 665..667 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 668..673 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 679..682 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 689..691 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 692..695 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 706..714 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 716..719 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 724..728 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 746..749 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 753..766 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 774..778 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 781..799 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 804..806 FT /evidence="ECO:0007829|PDB:5MHF" FT TURN 808..810 FT /evidence="ECO:0007829|PDB:5MHF" FT STRAND 813..818 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 822..825 FT /evidence="ECO:0007829|PDB:5MHF" FT HELIX 826..831 FT /evidence="ECO:0007829|PDB:5MHF" SQ SEQUENCE 834 AA; 91831 MW; CB2728BE16EACD0E CRC64; MARGERRRRA AAAEGARPLE RARAAGRRDG RAGGARGSAS GAALAVVVLA LAFGLSGRWV LAWLRVRRAL TLHPAPSALP PDSSSPAVAP ELFWGTYRPH VYFGMKTRSP KPLLTGLMWA QQGATPGTPP KLRHTCEQGD GVGPYGWEFH DGRTFGRQHI HDGALRLTTE FVKRPGGQHG GDWSWRVTVE PQASGTPSFP LVSLFFYVVT DGQEVLLPEI GAKGQLKSIS GHTSELGDFR LTLLPPTSPG DTVPKHGSYN VFWSSNPGLP QLTDMVKSRL NSWFQHRPPG ASPDRYLGLP GSLKWEERGP SGQGQFLIQQ VTLKAPFSVE FVFESGSAAT GGNQASGRLV GSQLTQALES HAAAFKERFE KTFQLKEKGL SPEEQALGQV ALSGLLGGIG YFYGQGLVLP DTSMEGSEQK MDPALFPPVP LFSGVPSRSF FPRGFLWDEG FHQLVVQRWD PHLTREALGH WLGLLNADGW IGREQILGDE ARARVPPEFL VQRAAHANPP TLLLPVVHML EGHDPDDLAF LRKAFPRLHA WFSWLHQSQA GPVPLSYRWR GRDLALPTLL NPKTLPSGLD DYPRASHPST AERHLDLRCW VALGARVLSQ LAEQLGETEA AAELGPLAAS LEEPGSLDEL HWAPELGVFA DFGNHTKAVQ LKSRPPQGLV RVVGRPPPRL QYVDALGYVS LFPLLLQLLD PSSPRLGPLL DVLADSRHLW SPFGLRSLSA SSLFYKQRNT EHDPPYWRGA VWLNINYLAL GALHHYGHVE GPHKVQAAKL YHELRANVVR NVRQQYQATG FLWEQYSDQD GRGMGCRPFQ GWTSLVLLIM AEEY //